Stephen Francis
Overview
Explore the profile of Stephen Francis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
3095
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santoro A, Moskowitz A, Ferrari S, Carlo-Stella C, Lisano J, Francis S, et al.
Blood
. 2023 Mar;
141(22):2780-2783.
PMID: 36898084
No abstract available.
2.
Harker-Murray P, Mauz-Korholz C, Leblanc T, Mascarin M, Michel G, Cooper S, et al.
Blood
. 2022 Dec;
141(17):2075-2084.
PMID: 36564047
Children, adolescents, and young adults (CAYA) with relapsed/refractory (R/R) classic Hodgkin lymphoma (cHL) without complete metabolic response (CMR) before autologous hematopoietic cell transplantation (auto-HCT) have poor survival outcomes. CheckMate 744,...
3.
Eckel-Passow J, Drucker K, Kollmeyer T, Kosel M, Decker P, Molinaro A, et al.
Neuro Oncol
. 2020 May;
22(11):1602-1613.
PMID: 32386320
Background: Twenty-five germline variants are associated with adult diffuse glioma, and some of these variants have been shown to be associated with particular subtypes of glioma. We hypothesized that additional...
4.
Stammers A, Francis S, Tesdahl E, Miller R, Nostro A, Mongero L
J Extra Corpor Technol
. 2020 Jan;
51(4):227-237.
PMID: 31915406
Autologous priming (AP) of the extracorporeal circuit has been used as a technique to reduce iatrogenic anemia in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). The purpose of this...
5.
Zinzani P, Santoro A, Gritti G, Brice P, Barr P, Kuruvilla J, et al.
J Clin Oncol
. 2019 Aug;
37(33):3081-3089.
PMID: 31398081
Purpose: Primary mediastinal B-cell lymphoma (PMBL) is a rare but aggressive non-Hodgkin lymphoma with poor outcomes in patients with relapsed/refractory (R/R) disease. PMBL is characterized by high expression of programmed...
6.
Wiemels J, Talback M, Francis S, Feychting M
Cancer Epidemiol Biomarkers Prev
. 2019 Apr;
28(6):1024-1027.
PMID: 30996022
Background: Congenital cytomegalovirus (CMV) infection was recently identified as a risk factor for childhood acute lymphocytic leukemia by detecting the presence of CMV sequences in neonatal blood spots. In this...
7.
Amin A, Lawson D, Salama A, Koon H, Guthrie Jr T, Thomas S, et al.
J Immunother Cancer
. 2016 Aug;
4:44.
PMID: 27532019
Background: Ipilimumab (IPI), an anti-CTLA-4 antibody, and vemurafenib (VEM), a BRAF inhibitor, have distinct mechanisms of action and shared toxicities (e.g., skin, gastrointestinal [GI] and hepatobiliary disorders) that may preclude...
8.
Clingan S, Schuldes M, Francis S, Hoerr Jr H, Riley J
Perfusion
. 2016 Mar;
31(7):552-9.
PMID: 26993481
Background: This study examines the efficacy of hypobaric oxygenation as it relates to the elimination of gaseous microemboli (GME) at designated flow, pressure and temperature combinations. Methods: Hypobaric oxygenation was...
9.
Dave V, Street K, Francis S, Bradman A, Riley L, Eskenazi B, et al.
Pediatr Res
. 2016 Jan;
79(6):846-54.
PMID: 26756784
Background: The childhood salivary microbiome, which plays an important role in healthy development, may be influenced by breast milk consumption. The composition of the milk microbiome and the role it...
10.
Robert C, Thomas L, Bondarenko I, ODay S, Weber J, Garbe C, et al.
N Engl J Med
. 2011 Jun;
364(26):2517-26.
PMID: 21639810
Background: Ipilimumab monotherapy (at a dose of 3 mg per kilogram of body weight), as compared with glycoprotein 100, improved overall survival in a phase 3 study involving patients with...